Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
03/2005
03/24/2005WO2004092144A3 Quinazoline compounds useful as p38 kinase inhibitors
03/24/2005WO2004089922A3 Calcium channel inhibitors comprising benzhydril spaced from piperazine
03/24/2005WO2004087653A3 4-ring imidazole derivatives as modulators of metabotropic glutamate receptor-5
03/24/2005WO2004087075A3 Compositions and methods for treating cancer
03/24/2005WO2004087074A3 Process for making substituted pyrazoles
03/24/2005WO2004087050A3 Mitotic kinesin inhibitors
03/24/2005WO2004073619A3 Ccr8 antagonists
03/24/2005WO2004072101A3 Phenylglycine derivatives useful as serine protease inhibitors
03/24/2005WO2004069160A3 Chemical compounds
03/24/2005WO2004067510A8 3,6-disubstituted azabicyclo hexane derivatives as muscarinic receptor antagonists
03/24/2005WO2004064789A3 Quaternary antimuscarinic compounds for the treatment of bladder diseases
03/24/2005WO2004064730A3 Compounds, compositions and methods
03/24/2005WO2004046113A3 Pyridine n-oxide compounds as phosphodiesterase 4 inhibitors
03/24/2005WO2004039795A3 Amide compounds for the treatment of hyperlipidemia
03/24/2005WO2004016607A8 Inhibition of phosphoinositide 3-kinase beta
03/24/2005WO2004002956A3 Asymmetric synthesis of amino-pyrrolidinones and a crystalline, free-base amino-pyrrolidinone
03/24/2005US20050065348 Pyridin-2-yl-methylamine derivatives for treating opioid dependence
03/24/2005US20050065343 Reacting 6-hydroxy-3,4-dihydroquinoline with 1-cyclohexyl-5-(halbutyl)tetrazole in presence of a base
03/24/2005US20050065191 Central nervous system disorders; therapy for diseases of glutamate receptor signal transmission
03/24/2005US20050065188 Aryl or heteroaryl amide compounds
03/24/2005US20050065186 Heterocyclyloxy-, -thioxy-and-aminobenzazole derivatives as 5-hydroxytryptamine-6 ligands
03/24/2005US20050065185 Heterocyclylalkoxy-, -alkylthio- and -alkylaminobenzazole derivatives as 5-hydroxytryptamine-6 ligands
03/24/2005US20050065179 Novel derivatives of benzimidazole and imidazo-pyridine and their use as medicaments
03/24/2005US20050065170 Compounds
03/24/2005US20050065166 Herbicides; plant safening agents
03/24/2005US20050065164 Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments
03/24/2005US20050065163 Platelet adenosine diphosphate receptor antagonists
03/24/2005US20050065162 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
03/24/2005US20050065161 Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds, compositions and their uses
03/24/2005US20050065155 Autoimmune disease ; antiinflammatory agents; antiischemic agents; rheumatic diseases; antiarthritic agents
03/24/2005US20050065148 Dipeptidyl peptidase inhibitors
03/24/2005US20050065145 Immunosuppressants; autoimmune disease; antiinflammatory agents; multiple sclerosis; rheumatic diseases; antiarthritic agents; aids; anticancer agents; skin disorders
03/24/2005US20050065144 Dipeptidyl peptidase inhibitors
03/24/2005US20050065140 Antidepressant; side effect reduction
03/24/2005US20050065095 Antibacterial agents
03/24/2005US20050064335 Indolestyryl compound for use in recording media and method for fabrication thereof
03/24/2005DE10339862A1 New crystalline forms of ethyl 3-(N-(2-(4-(hexyloxycarbonylamidino)ph enylaminomethyl)-1-methyl-1H-benzimidazole-5-carbonyl)-N-(2-pyridyl)a mino)propionate methanesulfonate used for post-operative prophylaxis of deep vein thrombosis
03/24/2005CA2541100A1 Quinazoline derivatives
03/24/2005CA2539160A1 Antibacterial agents
03/24/2005CA2539049A1 Quinazoline derivatives
03/24/2005CA2539024A1 Quinazoline derivatives as antitumor agents
03/24/2005CA2539022A1 Quinazoline derivatives as tyrosine kinase inhibitors
03/24/2005CA2538552A1 Pyrrol derivatives with antibacterial activity
03/24/2005CA2538413A1 2,4-di (phenylamino) pyrimidines useful in the treatment of proliferative disorders
03/24/2005CA2538410A1 2-pyridone derivatives as netrophil elastase inhibitors and their use
03/24/2005CA2538188A1 Dihydropyridine compounds for treating or preventing metabolic disorders
03/24/2005CA2537663A1 17-heterocyclic-4-azasteroid derivatives as androgen receptor modulators
03/24/2005CA2537660A1 17-heterocyclic-4-azasteroid derivatives as androgen receptor modulators
03/24/2005CA2536633A1 Fused ring heterocycles as potassium channel modulators
03/24/2005CA2534957A1 Antibiotic cycloalkyltetrahydroquinoline derivatives
03/24/2005CA2482232A1 Protease inhibitor conjugates and antibodies useful in immunoassay
03/23/2005EP1516877A1 Amine derivatives as protease inhibitors
03/23/2005EP1516876A1 Mediators of hedgehog signalling pathways, compositions and uses related thereto
03/23/2005EP1516875A1 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
03/23/2005EP1516874A1 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
03/23/2005EP1516871A1 Benzoindoline derivatives with adrenergic activity
03/23/2005EP1515965A1 Phenylaminopyrimidines and their use as rho-kinase inhibitors
03/23/2005EP1515964A1 Substituted diaminopyrimidines
03/23/2005EP1515963A2 A process for preparation of optically pure or optically enriched sulfoxide compounds, including amorphous esomeprazole and salts thereof
03/23/2005EP1515953A2 Novel hexahydro-pyridazine-3-carbocylic acid hydrazide or hydrazone derivatives, combinatorial libraries containing same, use thereof as medicines, pharmaceutical compositions containing same and methods for preparing same
03/23/2005EP1515951A1 Arylsulfonylhydroxamic acid and amide derivatives and their use as protease inhibitors
03/23/2005EP1515949A1 Mitotic kinesin inhibitors
03/23/2005EP1515945A2 Method for making aryl hydrazines and substituted indoles
03/23/2005EP1515944A1 Aspartyl protease inhibitors
03/23/2005EP1515724A1 Mitotic kinesin inhibitors
03/23/2005EP1515722A2 Ophthalmic compositions for treating ocular hypertension
03/23/2005EP1515721A1 Ophthalmic compositions for treating ocular hypertension
03/23/2005EP1419125A4 Kinetic resolutions of chirat 3- and 3-substituted carboxylic acids
03/23/2005EP1028949B1 Carbamoylphenylsulfonyl ureas, method for their production and their application as herbicides and plant growth regulators
03/23/2005CN1599736A Process for the preparation of 4-(8-chloro-5, 6-dihydro-11h-benzo(5, 6)-cyclohepta-(1, 2b)-pyridin-11-ylidene)-1-piperidinecarboxyli c acid ethyl ester (loratadine)
03/23/2005CN1599734A 3, 4-di-substituted maleimide compounds as CXC-chemokine receptor antagonists
03/23/2005CN1599733A N-ureido-piperidines as antagonists viii for CCR-3 receptor
03/23/2005CN1599726A Pyrimidine compounds
03/23/2005CN1599724A Imidazole-4-carboxamide derivatives, preparation and use thereof for treatment of obesity
03/23/2005CN1599722A 4-piperidinyl alkylamine derivatives as muscarinic receptor antagonists
03/23/2005CN1599720A Tetrahydrocarbazol derivatives as ligands for g-protein-coupled receptors (gpcr)
03/23/2005CN1599718A Sulphonamide derivatives, the preparation thereof and the application of same as medicaments
03/23/2005CN1599717A Cyclic diamine compounds having fused-ring groups
03/23/2005CN1599610A Preparation of pharmaceutical salts of 4((z)-(4-bromophenyl)(ethoxyimino)methyl)-1'-((2, 4-dimethyl-1-oxido-3-pyridinyl)carbonyl)-4'-methyl-1, 4'bipiperidine as ccr5-antagonists for the treatment of aid
03/23/2005CN1599607A Carbinols for the treatment of neuropathic dysfunction
03/23/2005CN1597680A New method of synthesizing thalidomide and its derivative
03/23/2005CN1597667A Quinazoline derivatives as angiogenesis inhibitors
03/23/2005CN1193788C Beta 2-adrenergic receptor agonist
03/22/2005US6870056 Substitituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade
03/22/2005US6870055 Heterocyclic amides such as 3-dimethylaminomethyl-6-methoxy-2 -methyl-4-phenyl-2H-isoquinoline-1-one, used as antiarrhythmic agents
03/22/2005US6869974 Pharmaceutical compounds
03/22/2005US6869966 N-substituted-2-oxodihydropyridine derivatives
03/22/2005US6869960 Substituted with a quinolin-3-ylmethyl- group, e.g., 2,3-dihydro-1'-((2-oxo-1,2,3,4-tetrahydro-3-quinolinyl)-methyl)spiro(1H -indene-1,4'-piperidine)
03/22/2005US6869957 Non-peptide tachykinin receptor antagonists
03/22/2005US6869953 N-monoacylated derivatives of o-phenylenediamines, their analogs and their use as pharmaceutical agents
03/22/2005US6869943 Sorbitol dehydrogenase inhibitors
03/22/2005US6869605 Anticarcinogenic agents
03/22/2005CA2330092C Benzimidazole compounds as orl1-receptor agonists
03/17/2005WO2005023807A2 4 - heterobicyclyamino - substituted quinazolines and analogues therof as capsaicin - antagonists
03/17/2005WO2005023798A1 2-substituted benzimidazole piperidines analogs as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders
03/17/2005WO2005023797A1 New salts of omeprazole and esomeprazole ii
03/17/2005WO2005023796A1 New salts of omeprazole and esomeprazole i
03/17/2005WO2005023795A1 Imidazole derivatives
03/17/2005WO2005023794A2 Compound libraries of 4-carboxamidopiperidine derivatives
03/17/2005WO2005023776A1 Pesticidal 5-substituted-oxyalkylamino-1-arylpyrazole derivatives
1 ... 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 ... 1080